89 related articles for article (PubMed ID: 10335519)
1. Lack of association of transforming growth factor (TGF)-beta 1 and beta 2 gene polymorphisms with multiple sclerosis (MS) in Northern Ireland.
McDonnell GV; Kirk CW; Hawkins SA; Graham CA
Mult Scler; 1999 Apr; 5(2):105-9. PubMed ID: 10335519
[TBL] [Abstract][Full Text] [Related]
2. Genetic association studies of tumour necrosis factor alpha and beta and tumour necrosis factor receptor 1 and 2 polymorphisms across the clinical spectrum of multiple sclerosis.
McDonnell GV; Kirk CW; Middleton D; Droogan AG; Hawkins SA; Patterson CC; Graham CA
J Neurol; 1999 Nov; 246(11):1051-8. PubMed ID: 10631637
[TBL] [Abstract][Full Text] [Related]
3. A study of the HLA-DR region in clinical subgroups of multiple sclerosis and its influence on prognosis.
McDonnell GV; Mawhinney H; Graham CA; Hawkins SA; Middleton D
J Neurol Sci; 1999 May; 165(1):77-83. PubMed ID: 10426152
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of interleukin genes fails to identify clear susceptibility loci for multiple sclerosis.
McDonnell GV; Kirk CW; Hawkins SA; Graham CA
J Neurol Sci; 2000 May; 176(1):4-12. PubMed ID: 10865086
[TBL] [Abstract][Full Text] [Related]
5. Influence of CCR5 delta32 polymorphism on multiple sclerosis susceptibility and disease course.
Silversides JA; Heggarty SV; McDonnell GV; Hawkins SA; Graham CA
Mult Scler; 2004 Apr; 10(2):149-52. PubMed ID: 15124759
[TBL] [Abstract][Full Text] [Related]
6. Gene expression and genotyping studies implicate the interleukin 7 receptor in the pathogenesis of primary progressive multiple sclerosis.
Booth DR; Arthur AT; Teutsch SM; Bye C; Rubio J; Armati PJ; Pollard JD; Heard RN; Stewart GJ;
J Mol Med (Berl); 2005 Oct; 83(10):822-30. PubMed ID: 16075257
[TBL] [Abstract][Full Text] [Related]
7. Pro- and anti-inflammatory cytokine gene polymorphism profiles in Bulgarian multiple sclerosis patients.
Mihailova S; Ivanova M; Mihaylova A; Quin L; Mikova O; Naumova E
J Neuroimmunol; 2005 Nov; 168(1-2):138-43. PubMed ID: 16183136
[TBL] [Abstract][Full Text] [Related]
8. CTLA4 gene polymorphisms and multiple sclerosis in Northern Ireland.
Heggarty S; Suppiah V; Silversides J; O'doherty C; Droogan A; McDonnell G; Hawkins S; Graham C; Vandenbroeck K
J Neuroimmunol; 2007 Jul; 187(1-2):187-91. PubMed ID: 17524498
[TBL] [Abstract][Full Text] [Related]
9. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.
Link J
Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782
[TBL] [Abstract][Full Text] [Related]
10. Significance of the tissue kallikrein promoter and transforming growth factor-beta1 polymorphisms with renal progression in children with vesicoureteral reflux.
Lee-Chen GJ; Liu KP; Lai YC; Juang HS; Huang SY; Lin CY
Kidney Int; 2004 Apr; 65(4):1467-72. PubMed ID: 15086490
[TBL] [Abstract][Full Text] [Related]
11. Expression of IFN-gamma, IL-4, and TGF-beta in multiple sclerosis in relation to HLA-Dw2 phenotype and stage of disease.
Söderström M; Hillert J; Link J; Navikas V; Fredrikson S; Link H
Mult Scler; 1995 Nov; 1(3):173-80. PubMed ID: 9345450
[TBL] [Abstract][Full Text] [Related]
12. Chromosome 19 locus apolipoprotein C-II association with multiple sclerosis.
Zouali H; Faure-Delanef L; Lucotte G
Mult Scler; 1999 Apr; 5(2):134-6. PubMed ID: 10335523
[TBL] [Abstract][Full Text] [Related]
13. Polymorphism R25P in the gene encoding transforming growth factor-beta (TGF-beta1) is a newly identified risk factor for proliferative diabetic retinopathy.
Beránek M; Kanková K; Benes P; Izakovicová-Hollá L; Znojil V; Hájek D; Vlková E; Vácha J
Am J Med Genet; 2002 May; 109(4):278-83. PubMed ID: 11992481
[TBL] [Abstract][Full Text] [Related]
14. Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosis.
Malhotra S; Fissolo N; Tintoré M; Wing AC; Castilló J; Vidal-Jordana A; Montalban X; Comabella M
J Neuroinflammation; 2015 Mar; 12():48. PubMed ID: 25879961
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility to relapsing-progressive multiple sclerosis is associated with inheritance of genes linked to the variable region of the TcR beta locus: use of affected family-based controls.
Hockertz MK; Paty DW; Beall SS
Am J Hum Genet; 1998 Feb; 62(2):373-85. PubMed ID: 9463308
[TBL] [Abstract][Full Text] [Related]
16. miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis.
Honardoost MA; Kiani-Esfahani A; Ghaedi K; Etemadifar M; Salehi M
Gene; 2014 Jul; 544(2):128-33. PubMed ID: 24792898
[TBL] [Abstract][Full Text] [Related]
17. Genetic association between polymorphisms in the ADAMTS14 gene and multiple sclerosis.
Goertsches R; Comabella M; Navarro A; Perkal H; Montalban X
J Neuroimmunol; 2005 Jul; 164(1-2):140-7. PubMed ID: 15913795
[TBL] [Abstract][Full Text] [Related]
18. Income in Multiple Sclerosis Patients with Different Disease Phenotypes.
Kavaliunas A; Manouchehrinia A; Danylaite Karrenbauer V; Gyllensten H; Glaser A; Alexanderson K; Hillert J
PLoS One; 2017; 12(1):e0169460. PubMed ID: 28081163
[TBL] [Abstract][Full Text] [Related]
19. Intravenous immunoglobulin in primary and secondary chronic progressive multiple sclerosis: a randomized placebo controlled multicentre study.
Pöhlau D; Przuntek H; Sailer M; Bethke F; Koehler J; König N; Heesen C; Späth P; Andresen I
Mult Scler; 2007 Nov; 13(9):1107-17. PubMed ID: 17623736
[TBL] [Abstract][Full Text] [Related]
20. An investigation of susceptibility loci in benign, aggressive and primary progressive multiple sclerosis in Northern Irish population.
Gray OM; Abdeen H; McDonnell GV; Patterson CC; Graham CA; Hawkins SA
Mult Scler; 2009 Mar; 15(3):299-303. PubMed ID: 19244395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
